Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Through AFP-Binding Receptors

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.